Technical analysis of NewAmsterdam Pharma Company N.V. (NAMS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases.
Price Performance
| 1 month | -6.02% |
| 3 months | -25.14% |
| Year-to-date | -40.34% |
| 1 year | -45.11% |
| 3 years | +102.81% |
| 5 years | +112.92% |
52-Week Range
| 52-week High | $42.21 |
| 52-week Low | $19.13 |
| Avg Volume (90d) | 1.4M |
Technical Indicators
| SMA 50 | $22.43 |
| SMA 200 | $29.62 |
| Beta | 0.13 |
| 30-day Volatility (annualised) | 51.6% |
| Price vs SMA 50 | -6.7% |
| Price vs SMA 200 | -29.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $35.08 | |
| 2026-01 | $31.12 | -11.3% |
| 2026-02 | $35.46 | +13.9% |
| 2026-03 | $32.01 | -9.7% |
| 2026-04 | $28.56 | -10.8% |
| 2026-05 | $33.68 | +17.9% |
| 2026-06 | $33.89 | +0.6% |
| 2026-07 | $27.79 | -18.0% |
| 2026-08 | $25.34 | -8.8% |
| 2026-09 | $24.32 | -4.0% |
| 2026-10 | $20.06 | -17.5% |
| 2026-11 | $20.93 | +4.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-17 | $-0.38 | $16M |
| 2026-11-04 | $-0.47 | $8M |
| 2026-08-05 | $-0.48 | $2M |
| 2026-05-07 | $-0.46 | $2M |
| 2026-02-18 | $-0.43 | $3M |
| 2025-11-05 | $-0.38 | $5M |
| 2025-08-06 | $-0.52 | $3M |
Price
| Price | $20.93 (closing price, November 4, 2026) |
| Market Cap | $2.4B |
| Exchange | NASDAQ |
| Country | NL |
Valuation Ratios
| Price / Book | 4.12 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 11.76 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 26.64 |